Weill Medical College of Cornell University Curriculum Vitae and Bibliography
Name: Heidi Stuhlmann, PhD
Date of Preparation: October 20, 2025
A. PERSONAL DATA
Office address: Department of Cell and Developmental Biology, A-312 Weill Cornell Medicine
1300 York Avenue, New York, NY 10065 Office telephone: 212-746-6156
Work email: hes2011@med.cornell.edu
Home address: 430 East 63rd Street, Apt. 8C, New York, NY 10065 Cell phone: 917-455-9274
Personal email: Hstuhlmann.gmail.com
Is your eligibility to work in the U.S. based on an employment visa?: No If yes, please provide Visa type (Examples: J-1, H-1B, E-3, TN, etc.): N/A
B. EDUCATION
Academic Degree(s)
Degree
Diploma-Vorprüfung
(Bachelor in Biological Sciences) Diploma in Biology/Microbiology (Masters in Biological Sciences) Doctor of Philosophy in Biological Sciences
Other Educational Experiences
Institution
University of Hamburg, Hamburg, Germany University of Hamburg, Hamburg, Germany University of Hamburg, Hamburg, Germany
Dates attended 03/1972 - 06/1976
07/1976 - 3/1979
04/1979 -05/1983
Year Awarded 1976
1979
1983
Description N/A
Institution Dates attended
C. POSTDOCTORAL TRAINING
Title, include area of training
Postdoctoral Fellow in Develop- mental Biology
Postdoctoral Fellow in Molecular Biology
Institution, city and state
Whitehead Institute & MIT, Cambridge, MA
Stanford University School of Medicine, Stanford, CA
Dates
06/1983 – 06/1987
07/1987 – 08/1991
D. PROFESSIONAL POSITIONS & EMPLOYMENT
Academic Appointments
Title Institution Dates
Assistant Professor of Molecular, Mount Sinai School of Medicine, 1991 – 1999
Cell & Developmental Biology New York, NY
Associate Professor of Vascular The Scripps Research Institute, 1999 – 2001
Biology La Jolla, CA
Associate Professor of Cell Biology, The Scripps Research Institute, 2001 – 2006
Division of Vascular Biology La Jolla, CA
Professor of Cell and Develop- Weill Cornell Medical College, 2006 – present mental Biology New York, NY
Professor of Cell and Develop- Weill Cornell Medical College, 2007 – present mental Biology in Pediatrics New York, NY
Adjunct Professor, Department College of Veterinary Medicine 2014 - present of Biomedical Sciences at Cornell University, Ithaca, NY
Acting Chair, Department of Weill Cornell Medical College, 2021 – present Cell & Developmental Biology New York, NY
Interim Chair, Department of Weill Cornell Medical College, 2021 – 2025
Biochemistry New York, NY
Hospital Appointments
Title Institution Dates N/A
Other Professional Positions & Employment
Title Institution Dates
Co-Chair, Biochemistry, Cell and Molecular Biology (BCMB) PhD program in the Weill Cornell Graduate School
Weill Cornell Medical College New York, NY
2020 - present
E. EMPLOYMENT STATUS
Name of Current Employer(s): Current Employment Status:
Full-time salaried by Weill Cornell
F. LICENSURE, BOARD CERTIFICATION
Licensure:
State Number Date of issue Date of last registration
N/A
If no license:
(1) Do you have a temporary certificate? NO
(2) Have you passed the examination for foreign medical school graduates? NO
Board Certification:
Full Name of Board Certificate # Dates of Certification N/A
G. INSTITUTIONAL/HOSPITAL AFFILIATION
Primary Hospital Affiliation: N/A
Other Hospital Affiliations: N/A
Other Institutional Affiliations: N/A
H. HONORS, AWARDS
Name of award Organization Date awarded
Undergraduate Scholarship Studienstiftung des Deutschen Volkes
Postdoctoral Fellowship Postdoctoral Fellowship Postdoctoral Research Fellowship
National Marfan Foundation Research Award
Basil O’Connor Starter Scholar Research Award
Harvey Klein Professorship of Biomedical Sciences
Dean’s Award for Excellence in Teaching and Mentoring Visiting Professorship
Dr. George N. Papanicolaou Grand Award
German National Academic Merit Foundation
Deutsche Forschungsgemeinschaft (DFG) National Multiple Sclerosis Society
Cystic Fibrosis Foundation National Marfan Foundation
March of Dimes Birth Defects Foundation Weill Cornell Medical College
Weill Cornell Graduate School of Medical
Sciences
University of Rome “Tor Vergata”, Italy The Hellenic Medical Society
1975 – 1979
1984 – 1986
1987 – 1988
1988 – 1991
1993
1993 – 1995
2010 – present
2011
2014
2025
I. PROFESSIONAL ORGANIZATIONS AND SOCIETY MEMBERSHIPS
Organization Date
North American Vascular Biology Organization (NAVBO)
American Heart Association (AHA), Council for Arteriosclerosis, Thrombosis & Vascular Biology
Society for Developmental Biology (SDB)
American Society for Investigative Pathology (ASIB) The Harvey Society, New York City
The New York Academy of Sciences
International Society for Stem Cell Research (ISSCR)
12/1999 – present 01/2002 – present
08/2004 – present 12/2005 – 2012
04/2007 – 2023
05/2012 – present 12/2022 - present
J. PERCENT EFFORT AND INSTITUTIONAL RESPONSIBILITIES
If joining WCM, report anticipated effort; if already WCM employed, report only WCM effort.
Weill Cornell Activity (Current or Anticipated) Percent Effort (%) Does the activity involve Weill Cornell students/research trainees? (Yes/No)
Teaching 10% Yes
Clinical 0% N/A
Administrative 30% Yes
Research 60% Yes
Total 100%
K. EDUCATIONAL CONTRIBUTIONS
Didactic teaching
Mount Sinai School of Medicine (1991 – 1999)
Advanced Molecular Biology: "Mouse Development" Fall 1992 CORE I: Molecular Biology for Ph.D. and MSTP students: "Protein Synthesis" Fall 1993 CORE I Molecular Biology for Ph.D. and MSTP students: "DNA dynamics" Fall 1994-98
(recombination, transposons, retrotransposons, DNA rearrangements and amplification, experimental applications)
Biochemistry I for MD students: "Gene transfer" Fall 1994-96 Developmental Biology for Ph.D. students: "Novel methods to study Spring 1995, mammalian development" Fall 1996
The Scripps Research Institute (TSRI) (1999-2006)
Teaching Activities at The Scripps Research Institute
Cell Biology Course (core course): “Developmental Aspects of Adhesion Spring 2001 – Mouse Models”
Neurobiology Course (elective course) “Stem Cells, Regeneration” Spring 2003 Cell Biology Course (core course) “Stem Cells and Tissue Renewal” Spring 2005
Teaching Activities at the University of California at San Diego (UCSD)
Molecular Biology of the Vascular System (elective course for Ph.D. Spring 2001 and MD /PhD students): “Vascular Development”
Weill Cornell Medical College (2006 – present)
Weill Cornell Medical School
Essentials Principles of Medicine (EPOM) “Developmental Biology and Fall 2014 E Epigenetic Lineage Specification”
Essentials Principles of Medicine (EPOM) “Vasculogenesis and Angiogenesis” Fall 2014-17 Essentials Principles of Medicine (EPOM) “Placenta, Placental Insufficiencies Fall 2018-25
and Disease”
Essentials Principles of Medicine (EPOM) “Mesoderm I:The Circulatory System” Fall 2025 Histology Labs:
11 lab instructions Fall 2010-13
3 lab instructions Fall 2014-25
Tri-Institutional MD-PhD Program
Frontiers in Biomedical Science I: “Molecular Genetics of Lymphangiogenesis” Spring 2007-08 Frontiers in Biomedical Science I: “Vascular System Development” Spring 2009-10
Spring 2016-20
Weill Cornell Graduate School of Medical Sciences
Developmental Biology Course: “Development of the Vascular System” Spring 2009 Principles of Developmental Biology Course: Fall 2011, 2013, 2015, 2017, 2019
“Endothelial and Hematopoietic Lineage Development”
Principles of Developmental Biology Course: Fall 2017, 2019, 2021, 2024 “Placental Development and Disease”
Stem Cell Biology Course: “Trophoblast Stem Cells” Fall 2018
Teaching Activities at the Gerstner Sloan-Kettering Graduate School
Development, Stem Cells and Morphogenesis Course: ”Angiogenesis” Spring 2015-20 “Angiogenesis”, 2-hour lecture plus 1-hour discussion session
Clinical teaching (bedside teaching, teaching rounds, teaching in operating room, precepting in clinic, morning report, etc.: N/A
Administrative teaching (leadership role as residency or fellowship director, course or seminar series director or co-director at WCM and previously employed institutions
Mount Sinai School of Medicine
Organizer and Participant, Interdepartmental Developmental Biology 1994-1999
Research Seminar Series "Embryo Group"
Weill Cornell Medical College
Course Director and Discussion Group Leader, 2011-2019
“Principles of Developmental Biology”
Course Co-Director, ”Stem Cell Biology” 2012-2018
Co-Chair, Cell and Developmental Biology section in the Biochemistry, Cell 2020-present and Molecular Biology (BCMB) program in the Weill Cornell Graduate School
Continuing education and professional education as teacher (role and scope of activity):
N/A
Other education/outreach:
N/A
L. CLINICAL PRACTICE, INNOVATION, and LEADERSHIP
Clinical Practice
N/A
Clinical Innovations
N/A
Clinical Leadership
N/A
M. RESEARCH
Research Activities:
Research in Dr. Stuhlmann’s lab is focused on understanding the developmental programs of the vascular system and the placenta, and stem cell biology.
The Stuhlmann lab studies the molecular and genetic pathways that regulate the three principal processes of vascular development: endothelial cell lineage determination, vasculogenesis, and angiogenesis. A combination of molecular, genetic and biochemical approaches using ESC, primary endothelial cells and mouse models are employed in these studies. The groundwork for our research program involved an expression-based “gene trap” screen in mouse embryonic stem (ES) cells and embryos. One of the novel genes identified in this genetic screen is Egfl7 (Epidermal growth factor-like domain 7), an early embryonic, endothelial-specific gene and a microRNA embedded in Egfl7, miR-
126. A second major focus in the Stuhlmann lab is to dissect regulatory pathways and epigenetic mechanisms in placental development and disease. We have established novel roles for Egfl7 and miR-126 in placental development. We have also established EGFL7 as a novel secreted factor that is associated with preeclampsia. Presently, we are investigating how miR-126 controls placental energy stores and glucose homeostasis in the adult, as well as the placenta-brain axis.
Research Support:
Current Research Funding
N/A
Past (Completed) Funding
National Institutes of Health, NIH/NICHD
5T32 HD060600-15
Project Title: “Training Program in Developmental and Stem Cell Biology” Program Director: H. Stuhlmann (no salary support)
Total direct costs: $1,010,859 (funding period 05/2020 – 04/2025) Project period: 09/2010 – 04/2025
Cornell Multi-PI Seed Grant
Project Title: SARS-CoV-2 Infection and Transposon Dysregulation in Placenta Program Directors: H. Stuhlmann (WCM), C. Feschotte (Cornell University) Total direct costs: $75,000
Project period: 01/2023 – 12/2023
Weill Cornell COVID-19 Research Grant
Project Title: The Placenta as a Potential Site of SARS-CoV-2 Infection and Transmission Principal Investigator: H. Stuhlmann
Total direct cost: $82,700
Project period: 08/2020 – 07/2021
NMSS -National Multiple Sclerosis Society (subaward)
Project Title: Endothelial Wnt signaling in CNS neo-angiogenesis and blood- brain barrier in EAE/MS
Project Period: 10/2019 – 09/2022
Principal Investigator: D. Agalliu, Columbia University Medical Center,
H. Stuhlmann, collaborator
National Institutes of Health, NIH/NIMH
5R01 MH083680-09
Project Title: “MicroRNA Function in the Development of Cerebral Cortex” Principal Investigators: H. Stuhlmann and Natalia V. De Marco Garcia Total direct costs: $750,000
Project period: 03/2017 – 6/2020
Weill Cornell Medical College Bridge Fund
Total costs: $50,000
Project period: 08/2017 – 07/2018
Seed grant, Center of Reproductive Genomics at Cornell University
P50 HD076210 (PI: P. Cohen)
Total costs: $10,000
Project Period: 07/2017 – 06/2018
National Institutes of Health, NIH/NICHD
3T32 HD060600-07S1
Project Title: “Diversity Supplement - Training Program in Developmental and Stem Cell Biology” Program Director: H. Stuhlmann (no salary support)
Total direct costs: $92,650 Project period: 09/2016 – 04/2018
National Institutes of Health, NIH/NHLBI
2R01 HL082098
Project Title: “Role of Egfl7 in Angiogenesis and Vascular Injury” Principal Investigator: H. Stuhlmann
Total direct costs: $1,000,000
Project period: 04/2007 – 03/2017
2014 March of Dimes General Research Fund
FY14-1676
Project Title: “Role of EGFL7 in Implantation, Placental Development and Pre-eclampsia” Principal Investigator: H. Stuhlmann
Total direct costs: $340,909 Project period: 06/2014 – 05/2017
Weill Cornell Institutional Funds
Project Title: “Investigating the genetic causes of idiopathic fetal nuchal edemas” Principal Investigator: H. Stuhlmann
Total direct costs: $100,000 Project period: 07/2010 - 06/2012
Tri-Institutional Stem Cell Initiative
Project Title: “EGF-like domain 7 (Egfl7) and endothelial stem/progenitor populations” Principal Investigator: Heidi Stuhlmann, Ph.D.
Total direct costs: $520,000 Project period: 10/2007 – 12/2010
Empire State Stem Cell Board (NYSTEM)
New York State Department of Health
Supplemental funds to the Tri-Institutional Stem Cell Initiative for the purchase of equipment. Principal Investigator: Heidi Stuhlmann, Ph.D.
Total direct costs: $45,687 Project period: 04/08-03/09
National Institutes of Health, NHLBI
1R01 HL068648
Project Title: “Molecular Regulation of Vascular Development” Principal Investigator: Heidi Stuhlmann, Ph.D., 50% effort Total direct costs: $900,000
Project period: 05/03 – 04/08 (year 5: no-cost extension)
National Institutes of Health, NHLBI
1R21 HL072270 (RFA)
Project Title: “Marking Progenitor Cell Lineages in the Vascular System” Principal Investigator: Heidi Stuhlmann, Ph.D., 50% effort
Total direct costs: $450,000 Project period: 09/02 - 07/06
National Institutes of Health, NHLBI
1R01 HL065738
Project Title: “Functional Analysis of Vezf1, a Novel Endothelial Marker” Principal Investigator: Heidi Stuhlmann, Ph.D., 50% effort
Total direct costs: $745,935
Project period: 02/00 - 01/05 (year-5: no-cost extension)
National Institutes of Health, NHLBI
1R01 HL065738-03S1, Supplement
Project Title: “Functional Analysis of Vezf1, a Novel Endothelial Marker” Principal Investigator: Heidi Stuhlmann, Ph.D.
Direct costs: $50,000 Project period: 02/02 - 01/03
National Institutes of Health, NIHLBI
P01 HL048728
Project Title: “Cell Adhesion Mechanisms in Vascular Biology” Principal Investigator: Mark H. Ginsberg, M.D.
Director, Core A: Heidi Stuhlmann, Ph.D., 10% effort Total direct costs: $296,124
Project Period: 09/02 - 08/04
American Heart Association, National Center
Grant-In-Aid #9950585N
Project Title: "Characterization of Vezf1, a Novel Marker for Endothelial Cells of the Developing Vascular System”
Principal Investigator: Heidi Stuhlmann, Ph.D., 10% effort Total direct costs: $150,000
Project period: 01/99 - 12/01
Mount Sinai School of Medicine
Fund for Research Program Development
Project Title: "Regulation of Vezf1 during Endothelial Differentiation and Angiogenesis”" Principal Investigator: Heidi Stuhlmann, Ph.D., 5% effort
Direct costs: $20,000 Project Period: 07/98 - 06/99
Council for Tobacco Research, Award #3869
Project Title: "Functional Analysis of oct-3 during Mammalian Development" Principal Investigator: Heidi Stuhlmann, Ph.D., 10% effort
Total direct costs: $226,920 Project Period: 01/95 - 12/98
American Heart Association, New York City Affiliate
Grant-in-Aid
Project Title: "Genetic Screen for Early Circulatory System Genes in Mouse Embryonic Stem Cells" Principal Investigator: Heidi Stuhlmann, Ph.D., 10% effort
Total direct costs: $121,500 Project Period: 07/95 - 06/98
National Institutes of Health, CHHD
Award #: R29 HD31534
Project Title: "Identification of Genes Regulating Mammalian Gastrulation" Principal Investigator: Heidi Stuhlmann, Ph.D., 50% effort
Total direct costs: $350,000 Project Period: 12/94 - 11/99
Basil O'Connor Starter Scholar Research Grant, March of Dimes Foundation
Grant # 5-FY93-0915
Project Title: "Retroviral-Mediated Screening for Developmentally Regulated Genes in Mouse ES cells”
Principal Investigator: Heidi Stuhlmann, Ph.D., 15% effort Total direct costs: $55,640
Project Period: 09/93 - 08/95
National Marfan Foundation
Project Tile: "Towards a Mouse Model for Marfan Syndrome" Principal Investigator: Heidi Stuhlmann, Ph.D., 10% effort Direct costs: $10,000
Project Period: 01/93 - 12/93
Pending Funding
National Institutes of Health, NIAID
Project Title: “Maternal-fetal immune regulation via gut microbiome-driven T cells” Principal Investigator: Melody Zeng, Ph.D.
Heidi Stuhlmann, PhD., co-Investigator Effort: 5%
(Grant was approved by NIAID council 05/2025; awaiting NOA)
Patents & Inventions
N/A
N. MENTORING
Leadership and mentoring in programs
Mount Sinai School of Medicine
Organizer and Participant, Interdepartmental Developmental Biology 1994-1999
Research Seminar Series "Embryo Group"
Weill Cornell Medical College
Course Director and Discussion Group Leader, “Principles of Developmental Biology” 2011-2019
Course Co-Director, ”Stem Cell Biology” 2012-2018
Program Director, NIH supported pre-doctoral Training Program in Developmental and Stem Cell Biology (T32 HD060600) 2010-2025
Co-Chair, Cell and Developmental Biology section in the Biochemistry, Cell and Molecular Biology (BCMB) program in the Weill Cornell Graduate School 2020-present
Institutional Training Grants and Mentored Trainee Grants Mount Sinai School of Medicine
Participating faculty member in interdisciplinary programs supported by NIH training grants:
MSTP Training program Developmental Biology Training grant
Cardiovascular Research Training grant Renal Training Grant
The Scripps Research Institute (1999-2006)
Participating faculty member in NIH-supported training programs:
Graduate Program in Macromolecular and Cellular Structure and Chemistry, TSRI (2000–2006) Vascular Biology, Thrombosis and Hemostasis, supported by T32 HL007695 (2000-2006) Blood Systems in Coagulation and Vessel Disease, supported by T32 HL007195 (2002-2006)
Weill Cornell Medical College (2006–present)
Participating faculty member in grant-supported training programs
Tri-Institutional MD/PhD Program in New York City 2007-present Training Program in Developmental and Stem Cell Biology, T32 HD060600 2010-2025
Training Program in Molecular and Cellular Biology, T32 GM0008539 2007-2015
Weill Cornell Training Program in Stem Cell Biology and Regenerative Medicine, 2007-2012; supported by New York State, the Department of Health and the Empire 2018-2023
State Stem Cell Board, NYSTEM C026878
Mentees
Current Mentees:
N/A
Past Mentees:
Mount Sinai School of Medicine (MSSM, 1991-1999)
Name Jing-Wei Xiong, PhD
Site/Position MSSM, Postdoctoral fellow
Mentoring Period 1994-1999
Current Position Professor, College of Future Technology, Peking University, China
Type of Supervision Research
Name Ricardo Battaglino
Site/Position MSSM, Graduate student
Mentoring Period 1992-1999 (PhD degree)
Current Position Professor, University of Miami Miller School of Medicine
Type of Supervision Research
Name Amy Leahy
Site/Position MSSM, Graduate student
Mentoring Period 1995-1999 (PhD degree)
Current Position Patent lawyer, Soltego
Type of Supervision Research
Name Frank Kuhnert
Site/Position MSSM, Graduate student
Mentoring Period 1995-2003 (PhD degree) (moved to TSRI 2000)
Current Position Director, Oncology/Immune Oncology, Regeneron
Type of Supervision Research
Names of additional trainees Summer Undergraduate Students:
Frank Goldberg (1993), Debra Wassarman (1994)
The Scripps Research Institute (TSRI, 1999-2006)
Name Luisa Campagnolo, PhD
Site/Position TSRI, Postdoctoral fellow
Mentoring Period 2000-2003
Current Position Professor, University of Rome “Tor Vergata”, Rome, Italy
Type of Supervision Research
Name Zhongmin Zou, MD, PhD
Site/Position TSRI, Postdoctoral fellow
Mentoring Period 2002 - 2005
Current Position Professor, Third Military Medical University, ChongQing, China
Type of Supervision Research
Name Michael Fitch, PhD
Site/Position TSRI, Postdoctoral fellow
Mentoring Period 2001-2006
Current Position Technical Operations Leader, Turnstone Biologicals
Type of Supervision Research
Name Michael J. Gregory, PhD
Site/Position TSRI, Postdoctoral fellow
Mentoring Period 2003-2004
Current Position Program Analyst, U.S. Navy Medical Service Corps
Type of Supervision Research
Name Smita Chitnis, PhD
Site/Position TSRI, Postdoctoral fellow
Mentoring Period 2003-2006
Current Position Associate Scientist, Meso Scale Diagnostics Gaithersburg, MD
Type of Supervision Research
Name John D. Lewis, PhD
Site/Position TSRI, Postdoctoral fellow
Mentoring Period 2004-2006
Current Position Professor and Chair, Department of Oncology, University of Alberta, Edmonton, CN
Type of Supervision Research
Name Anna Durrans, PhD
Site/Position TSRI, Postdoctoral fellow
Mentoring Period 2004-2006 (moved to WCMC in 2006)
Current Position Research Programme Manager, Arthritis UK, Chesterfield, England
Type of Supervision Research
Name Marco Schroeter, MD, PhD
Site/Position TSRI, visiting postdoctoral fellow
Mentoring Period 2005
Current Position Professor, Department of Cardiology and Pneumology, Universitätsmedizin Göttingen, Germany
Type of Supervision Research
Names of additional trainees Diploma students:
Karsten Pönitzsch (University of Jena, Germany) 2002 Elodie Kleinmann (University of Strasbourg, France) 2004 Undergraduate student:
Alexander Perez (UCSD) 2003-2005
Weill Cornell Medical College (2006 – present)
Name Anna Durrans, PhD
Site/Position WCM, Postdoctoral fellow
Mentoring Period 2006-210
Current Position Research Programme Manager, Arthritis UK, Chesterfield,
England
Type of Supervision Research
Name Pauline Ocaya, PhD (obtained MD in
Site/Position WCM, Postdoctoral fellow
Mentoring Period 2007-2010
Current Position Physician and Infectious Disease Scientist, University of Umea, Sweden
Type of Supervision Research
Name Donna Nichol, PhD
Site/Position WCM, Postdoctoral fellow
Mentoring Period 2007-2013
Current Position Global Marketing Director, Oncology CDx at Amgen
Type of Supervision Research
Name Jeroen Bastiaans, PhD
Site/Position WCM, Postdoctoral fellow
Mentoring Period 2018-2022
Current Position Senior Scientist, MeiraGTx, New York, NY
Type of Supervision Research
Name Alka Rani, PhD
Site/Position WCM, Postdoctoral fellow
Mentoring Period 2022-2023
Current Position Postdoctoral researcher, University of South Florida
Type of Supervision Research
Name Stephanie Adams, BS
Site/Position WCM, Graduate student
Mentoring Period 2007-2010 (M.S.,left for medical reasons)
Current Position Scientist, Tizona Therapeutics, South San Francisco
Type of Supervision Research
Name Kathryn Bambino, BS
Site/Position WCM, Graduate student
Mentoring Period 2008-2013 (PhD degree)
Current Position Associate Director, Scientific Communications at The Estee Lauder Companies. Inc.
Type of Supervision Research
Name Lauretta A. Lacko, BS
Site/Position WCM, Graduate student
Mentoring Period 2010-2015 (PhD degree)
Current Position Assistant Professor of Cell Biology Research in Medicine, WCM
Type of Supervision Research
Name Abhijeet Sharma, BS
Site/Position WCM, Graduate student
Mentoring Period 2013-2017
Current Position Senior Scientist, PTC Therapeutics, Inc., New York,NY
Type of Supervision Research
Name Lissenya Argueta, BA
Site/Position WCM, Graduate student
Mentoring Period 2016-2022 (PhD degree)
Current Position Assistant Director, Clinical Research Methodology, Worldwide Clinical Trials
Type of Supervision Research
Name Jia Li, BS
Site/Position WCM, Visiting Graduate student, Beijing University, China
Mentoring Period 2009
Current Position Faculty, Department of Medicine, Columbia University
Type of Supervision Research
Names of additional trainees Undergraduate summer students:
Vanish Grover (Cornell University) 2007
James Mtui (Gateway URM student, SUNY Baffalo) 2007 Candice King (ACCESS URM student, Medgar Evers College) 2008
Jenna Walters (Hunter College) 2008-2009
John A. Campbell (Gateway URM student, North Carolina State University) 2009
Keven Cabrera (ACCESS URM student, Vassar College) 2011 Stephanie Cevallos (ACCESS URM student, Hunter College) 2012
Tiarra Joell (ACCESS URM student, Claflin University) 2014 Marguerite Pacheco (ACCESS URM student, Smith College) 2017
Brandon Cho (Cornell University) 2025
WCM medical student interns:
Sarah Eskreis-Winkler, summer 2008 Elizabeth Stewart, summer 2012 Clare Burke, summer 2015
WCM AOC (area of concentration) medical students:
Clare Burke, spring 2017 Brienne Lubor, spring 2020 Medical fellow:
Inna V. Landres MD, 2008-2010 (present position: Assistant Professor in Maternal-Fetal Medicine, WCM-NYP
O. INSTITUTIONAL LEADERSHIP ACTIVITIES
Role(s)/Position Institution/Location Dates
Co-Chair, BCMB (Cell and Developmental Biology section) PhD program in the WCM Graduate School
Program Director, T32 Training grant in Developmental Biology (supported by T32 HD060600)
WCM 2020-present
WCM 2010-2025
Interim Chair, Department of Biochemistry WCM 2021-2025
Acting Chair, Department of Cell & Developmental Biology WCM 2021-present
P. INSTITUTIONAL ADMINISTRATIVE ACTIVITIES
Name of Committee Role Dates
Advisory Committees for year-1 MSSM Ph.D. and MSTP Member, MSSM (Mount 1992-1999
students
Thesis Advisory Committees for PhD and MSTP students Sinai School of Medicine) Member, MSSM 1992-1999
Dean's Advisory Group for "Dean's Lecture Series" Member, MSSM 1992-1999
Admissions Committee for Sigma Xi-Rudin Foundation Member, MSSM 1994
Fellowships
Thesis Advisory Committees for PhD students Member, TSRI (The Scripps Research Institute) 1999-2006
Ad-hoc committee for recruitment and promotions, Dept. Member, TSRI 2000-2001
of Vascular Biology, TSRI (2000-2001)
Vascular Biology Affinity Group seminars Co-organizer, TSRI 2000-2003
Cell and Molecular Biology Affinity Group seminar series Co-organizer, TSRI 2003-2006
Thesis ACE, advisory, and defense Committees for PhD Member, WCM 2006-present
students
Promotions and Tenure Review Committee, Member, WCM 2007-2014
Department of Cell & Developmental Biology
Research Awards Committee Member, WCM 2007-2009
Chair, WCM 2009-2012
Faculty Recruitment Committee, Dept. of Pediatrics Member, WCM 2007-2008
Faculty Recruitment Committee, Dept. of Surgery Member, WCM 2007-2008
Cancer Center Core Review Committee Member, WCM 2008-2009
Strategic Plan III Faculty Recruitment Committee, Developmental and Stem Cell Biology Member, WCM 2008-2012
Admissions Committee, Tri-Institutional MD/PhD program Member, WCM 2009-2019
Recruitment Committee, Dept. of Medicine, Division of Member, WCM 2010-2011
Cardiology
Recruitment Committee, Dept. of Cell & Developmental Member, WCM 2010-2013
Biology
Steering Committee of “Cancer Networking Group” Member, WCM 2011-2013
WCMC Seed Grants ad hoc review committee Member, WCM 2014
Research Core Executive Committee Member, WCM 2014-2015
Leadership in Academic Medicine Program (LAMP) Mentor, WCM 2014-2015
T32 Director Working Group Member, WCM 2014-present
Institutional Biosafety Committee (IBC) Member, WCM 2014-2019
WCMC Area of Concentration (AOC) “Development and Co-leader, WCM 2014-present
Human Disease”
Basic Science Recruitment Committee Member, WCM 2015
Reproductive Medicine Search Committee Member, WCM 2015
Dean’s Family Friendly Postdoc-Initiative Committee Member, WCM 2015-2021
Committee on Admissions (CoA), Weill Cornell Medical College Member, WCM 2015-2019
Planning Committee, Weill Cornell “Initiative in Member, WCM 2016
Fundamental Genetics”
Voting basic science faculty member, Scholarship Member, WCM 2016-2017
Committee
Kellen Junior Faculty Awards Committee Member, WCM 2016-2018
Intramural Review Committee of the Pharmacology Program, Weill Cornell Graduate School Member WCM 2016-2017
Assistant Dean for Research Search Committee Member, WCM 2016-2017
Search Committee for Weill Cornell Graduate School Member, WCM 2018
Dean
Academic Integration Advisory Council – Weill Cornell Member, WCM and 2018-2022
and Cornell Ithaca Cornell University
Research Awards Committee Member, WCM 2020-2021
CVRI Faculty Search Committee Member, WCM 2020, 2022
Dean’s Strategic Space Planning Task Force Member, WCM 2021-2023
Scientific Realignment SP4-Lifespan Member, WCM 2021-2023
Executive Committee, Cornell Reproductive Center Member, Cornell University 2021-present
(CoRe), Cornell University and WCM
Women’s Leadership Council Member, WCM 2021-present
Siegel Award Committee Member, WCM 2023-2024
WCM-Q Cell Biology Recruitment Committee Member, WCM 2024-2025
Q. EXTRAMURAL PROFESSIONAL RESPONSIBILITIES
Leadership in Extramural Organizations
Organization Role Dates
North American Vascular Biology Organization (NAVBO)
Council Member 2008-2011
Service on Boards and/or Committees
Regional
Name of Committee Role Organization (Institution/Location) Dates
New York Metropolitan Co-organizer WCM, Columbia University, Mount 2008-2010
Angiogenesis/Vascular Development Club (NY MAC) Sinai School of Medicine, NYU
NYC Placenta Workshop Co-organizer WCM, Columbia University 2015-2020
Cornell Intercampus Symposium Co-organizer WCM, Cornell University 2022
Cornell Intercampus Symposium Co-organizer WCM, Cornell U, Cornell Tech 2025
National
Name of Committee Role Organization (Institution/Location) Dates
Meritorious Awards Committee Member North American Vascular Biology
Organization (NAVBO)
2015-2018
International
Name of Committee Role Organization (Institution/Location) Dates N/A
Grant Reviewing/Study Sections
Organization Name
Ad Hoc Member, Experimental Cardiovascular Sciences (ECS) Study Section Dates
2000-2001
NIH/NHLBI
Member, Peer Review Committee 3A, AHA Western States Affiliate 2001-2003
Chartered Member, Experimental Cardiovascular Sciences (ECS) Study Section, 2002-2003
NIH/NHLBI (Expired 10/03)
Chartered Member, Cardiovascular Differentiation and Development (CDD) Study
2004-2007
Section, NIH/NHLBI
Ad Hoc Reviewer, Special Emphasis Panel ZHD1 DRG-D, NIH/NICHD 04/2004
Ad Hoc Reviewer, Special Emphasis Panel ZRG1 CRFS-C, NIH/NIAID 02/2005
External Reviewer for Genome Canada, Competition III 04/2005
Ad Hoc Reviewer, Special Emphasis Panel ZRG1 CVS-Q, NIH/NHLBI 03/2007
Ad Hoc Reviewer, 2007 Whitehead Fellowship for Junior Faculty in Biomedical and 07/2007
Biological Sciences, NYU
Ad Hoc Reviewer, Special Emphasis Panel ZRG1 CVS-E, NIH/NHLBI 11/2007
Ad Hoc Reviewer, March of Dimes 03/2008
Ad Hoc Reviewer, Heart, Lung, and Blood Program Project Review Committee HLBP NIH/NHLBI 12/2008
Ad Hoc Reviewer, Special Emphasis Panel ZRG1 CVS-P, NIH/NHLBI 03/2009
Ad Hoc Reviewer, Heart, Lung, and Blood Program Project Review Committee HLPB 1, NIH/NHLBI 05/2010
Ad Hoc Reviewer, Special Emphasis Panel ZRG1 BDA-P (90) S, NIH/NHLBI 10/2010
Ad Hoc Reviewer, Heart, Lung, and Blood Program Project Review Committee 05/2012
HLPB 1, NIH/NHLBI
SFB (Sonderforschungsbereich)/Transregio 23, DFG (Deutsche 02/2013
Forschungsgemeinschaft), Germany
Ad Hoc Reviewer, The Icelandic Centre for Research – RANNIS, Iceland 11/2013
Ad Hoc Reviewer, NIH/NICHD Institutional Training Grant (T32) Review Committee ZHD1 RG-D(90) 01/2014
Ad Hoc Reviewer, Spec. Emphasis Panel NIH ZRG1 VH-B (02) M 04/2014
Ad Hoc Reviewer, Marsden Fund, Royal Society of New Zealand 07/2014
Ad Hoc Reviewer, Spec. Emphasis Panel NIH ZRG1 CVRS-E (02) M 12/2014
Ad Hoc Reviewer, Spec. Emphasis Panel NIH ZRG1 CVRS-C (02) 03/2014
Ad Hoc Reviewer, NHLBI Outstanding Investigator Award (R35), Inaugural Review 07/2016
Session
Ad Hoc Reviewer, NIH/NICHD Institutional Training Grant (T32) Review Committee ZHD1 DRG-D(90) 12/2016
Ad Hoc Reviewer, Pregnancy and Neonatology (PN) Study Section 02/2017
Ad Hoc Reviewer, NIH/NICHD ZRG1 EMNR-W M 10/2017
Ad Hoc Reviewer, NIH/NICHD ZRG1 EMNR-C (02) 03/2018
Ad hoc Reviewer, NIH/NICHD ZRG1 EMNR-C (02) 0/2019
Ad hoc Reviewer, Pregnancy and Neonatology (PN) Study Section 10/2020
Welcome Trust Peer Review 02/2021
Ad hoc Reviewer, NIH/NICHD ZRG1 EMNR-G (02) 03/2021
NIH-NICHD Special Emphasis Panel (SEP)/Scientific Review Group 2023/01 ZHD1 12/2022
DSR-Z (1) P50 review
Ad hoc Reviewer, NIH ZRG1 EMS-W (80) 07/2025
Welcome Trust Peer Review 08/2025
Editorial Activities
Editor/Co-Editor: N/A
Journals/ Textbooks / Books: N/A
Editorial Board Membership: Stem Cells, 2004- present
Ad hoc/Journal Reviewing:
Angiogenesis; Arteriosclerosis, Thrombosis, and Vascular Biology; Blood; Cell Communication and Signaling; Clinical Science; Development; Developmental Dynamics; eLife; FEBS Journal; JAHA; Journal of Angiogenesis; Journal of Experimental Medicine; Journal of Thrombosis and Haemostasis; Journal of Pathology; Lung Cellular and Molecular Physiology; Mechanisms of Development; Differentiation; Molecular Biology of the Cell; Molecular and Cellular Biology; Pediatric Pulmonology; Placenta; Science Translational Medicine; Stem Cells; Stem Cell Reports; Stem Cells and Development; Vascular Cell
R. INVITED LECTURES/PRESENTATIONS
Key Conference Talks since 2006
EGF-like domain 7 (Egfl7): a novel mediator of endothelial Notch signaling? Blood Vessel Club at Experimental Biology/NAVBO 2007, Washington, DC. Platform talk.
Role of Egfl7 during vascular development. Experimental Biology/NAVBO, 2008, San Diego, CA. Platform talk.
Egfl7 and its role in vascular development. International Symposium “Vascular Differentiation and Development”, 2008, Frankfurt, Germany.
Egfl7 over-expression and knock-down affects angiogenesis and germ cell development.
NAVBO Developmental Vascular Biology Workshop IV, 2010, Asilomar, CA. Platform talk.
VEZF1 is a transcriptional regulator of blood and lymphatic vascular development and is down- regulated in fetuses with abnormal nuchal translucency. NAVBO Genetics and Genomics of Vascular Disease Workshop II, 2012, Asilomar, CA. Platform talk.
EGFL7 in stem/progenitor cells of the endothelial and hematopoietic lineage. NAVBO Vascular Biology 2013 Meeting, Hyannis, MA. Platform talk.
Egfl7 is an early marker specific for the endothelial lineage and hemogenic endothelium. NAVBO Developmental Vascular Biology and Genetics Workshop, 2014, Asilomar, CA. Platform talk.
Egfl7 and miR-126 are required for normal placental development. NAVBO Vascular Biology 2015 Meeting, Hyannis, MA. Platform talk.
EGFL7 and miR-126: Novel Players in Placental Development and Disease. 2016 Northeast Regional Meeting of the Society for Developmental Biology, Woods Hole, MA. Invited speaker, talk.
Feto-placental vasculature in Development and Disease. NAVBO webinar. June 11, 2020.
miR-126 functions as a novel sex-specific regulator of the placenta-brain axis. Keystone Symposium: Maternal-Fetal Crosstalk: From Association to Mechanism/Infections in Pregnancy: Pathogenic Mechanisms, Experimental Advances and Clinical Strategies, January 22-26, 2023, in Santa Fe, NM. Plenary talk.
Impact of SARS-CoV-2 on the placenta. Cornell Intercampus Symposium, “Making Connections: Impact of mosquitoes and vector-borne diseases on reproductive health”. November 14-15, 2022. Scheduled talk.
Placental miR-126 and its role in fetal programming. Tri-Repro Symposium, Cornell University, April 27-28, 2023. Invited talk.
Placental development and its role in maternal-fetal health and disease. 2024 Intercampus Research Symposium, “Preventing Maternal Mortality and Morbidity: Preconception through Pregnancy, the 4th Trimester, and Beyond. October 21-22, 2024.
Developmental programming for defects in glucose metabolism. Cornell Intercampus Symposium “Advancing Reproductive Health through Basic and Clinical Research”, April 14-15, 2025. Scheduled talk.
Invited Seminars since 2006 (selected seminars)
Beth Israel Deaconess Medical Center, Harvard Medical School: February 24, 2006.
Department of Molecular, Cell & Developmental Biology, University of California Los Angeles, CA: May 23, 2006.
Sidney Kimmel Cancer Center, Vascular Biology and Angiogenesis Program, San Diego, CA: August 2, 2006.
Cornell University College of Veterinary Medicine, Department of Biomedical Sciences, Ithaca, NY: January 30, 2007.
Massachusetts General Hospital, Harvard Medical School, Nephrology Division, Boston, MA: March 11, 2008.
Yale University School of Medicine, Vascular Biology and Therapeutics Program, New Haven, CT: April 21, 2008.
Center for Vascular Biology Research (CVBR), Beth Israel Deaconess Medical Center, Harvard Medical School (CVBR Visiting Professor): November 10, 2010.
Department of Public Health and Cell Biology, University of Rome “Tor Vergata”, Rome, Italy (Visiting Professorship): May 29, 2014.
Cornell University, Reproductive Physiology/Endocrinology Seminar Series: March 25, 2015. Virginia Tech, Life Sciences Seminar, Blacksburgh, VA: March 25, 2016.
Retreat of the CMBS Integrated Graduate School Program at Columbia University, Glen Cove, NY (Invited Keynote Speaker): July 17-20, 2016.
Lecture at Maternal and Child Nutrition and Health seminar series: “Placental development and metabolic health”, Cornell University. March 19, 2024.
S. BIBLIOGRAPHY
Peer-reviewed Research Articles:
Jähner, D., Stuhlmann, H., and Jaenisch, R. (1980). Conformation of free and of integrated Moloney leukemia virus proviral DNA in preleukemic and leukemic BALB/Mo mice. Virology 101 (1): 111-123. PMID: 7355573
Stuhlmann, H., Jähner, D., and Jaenisch, R. (1981)*. Infectivity and methylation of retroviral genomes is correlated with expression in the animal. Cell 26 (2): 221-232. PMID: 6277495
*Featured in “Cell Line”, a “timeline featuring Cell papers published through the decades and the impact they have had on researchers today” (http://www.cell.com/cell/cell-timeline-40)
Harbers, K., Schnieke, A., Stuhlmann, H., Jähner, D., and Jaenisch, R. (1981). DNA methylation and gene expression: endogenous retroviral genome becomes infectious after molecular cloning. Proc. Natl. Acad. Sci. USA 78(12): 7609-7613. PMID: 6950402
Jaenisch, R., Harbers, K., Jähner, D., Stewart, C. L., and Stuhlmann, H. (1982). DNA methylation, retroviruses, and embryogenesis. J. Cell. Biochem. 20(4): 331-336. PMID: 7183678
Harbers, K., Schnieke, A., Stuhlmann, H., and Jaenisch, R. (1982). Infectivity and structure of molecular clones obtained from two genetically transmitted Moloney leukemia proviral genomes. Nucleic Acids Res. 10(8): 2521-2537. PMID: 6281733
Chumakov, I., Stuhlmann, H., Harbers, K., and Jaenisch, R. (1982). Cloning of two genetically transmitted Moloney leukemia proviral genomes: Correlation between biological activity of the cloned DNA and viral genome activation in the animal. J. Virol. 42(3): 1088-1098. PMID: 6284989
Stewart, C. L., Stuhlmann, H., Jähner, D., and Jaenisch, R. (1982). De novo methylation, expression, and infectivity of retroviral genomes introduced into embryonal carcinoma cells. Proc. Natl. Acad. Sci. USA 79(13): 4098-4102. PMID: 6955793
Jähner, D., Stuhlmann, H., Stewart, C. L., Harbers, K., Löhler, J., Simon, I., and Jaenisch, R. (1982). De novo methylation and expression of retroviral genomes during mouse embryogenesis. Nature 298(5875): 623-628. PMID: 6285203
Jähner, D., Stewart, C. L., Stuhlmann, H., Harbers, K., and Jaenisch, R. (1983). Retroviruses and embryogenesis: De novo methylation activity involved in gene expression. Cold Spring Harb. Symp. Quant. Biol. 47: 611-619. PMID: 6285203
Jaenisch, R., Harbers, K., Jähner, D., Stewart, C., and Stuhlmann, H. (1983). Expression of retroviruses during early mouse embryogenesis. Haematol Blood Transf. 28: 270-274. PMID: 6862303
Schnieke, A., Stuhlmann, H., Harbers, K., Chumakov, I., and Jaenisch, R. (1983). Endogenous Moloney leukemia virus in nonviremic Mov substrains of mice carries defects in the proviral genome. J. Virol. 45(2): 505-513. PMID: 6834466
Simon, D., Stuhlmann, H., Jähner, D., Wagner, H., Werner, E., and Jaenisch, R. (1983). Retrovirus genomes methylated by mammalian but not bacterial methylase are non-infectious. Nature 304(5923): 275-277. PMID: 6306480
Stuhlmann, H., Cone, R., Mulligan, R. C., and Jaenisch, R. (1984). Introduction of a selectable gene into different animal tissue by a retrovirus recombinant vector. Proc. Natl. Acad. Sci. USA 81(22): 7151-7155. PMID: 6095271
Stuhlmann, H., Jaenisch, R., and Mulligan, R. C. (1989). Construction and properties of replication-competent murine retroviral vectors encoding methotrexate resistance. Mol. Cell. Biol. 9(1): 100-108. PMID: 2927389
Stuhlmann, H., Jaenisch, R., and Mulligan, R. C. (1989). Transfer of a mutant dihydrofolate reductase gene into pre- and postimplantation mouse embryos by a replication-competent retrovirus vector. J. Virol. 63(11): 4857-4865. PMID: 2795720
Stuhlmann, H., Dieckmann, M., and Berg, P. (1990). Transduction of cellular neo mRNA by retroviral mediated recombination. J. Virol. 64(12): 5783-5796. PMID: 1700824
Stuhlmann, H. and Berg, P. (1992). Homologous recombination of co-packaged retroviral RNAs during reverse transcription. J. Virol. 66(4): 2378-2388. PMID: 1372369
Liu, R., Paxton, W. A., Choe, S.C., Ceradini, D., Martin, S.R., Horuk, R., MacDonald, M.E., Stuhlmann, H., Koup, R.A., and Landau, N.R. (1996). Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiple-exposed individuals to HIV-1 infection. Cell 86(3): 367-377. PMID: 8756719
Thöny, B., Leimbacher, W., Stuhlmann, H., Heizmann, H., and Blau, N. (1996). Retrovirus- mediated gene transfer of 6-pyruvolyl-tetrahydropterin synthase corrects tetrahydrobiopterin deficiency in fibroblasts from hyperphenylalaninemic patients. Hum. Gene Ther. 7(13): 1587- 1593. PMID: 8864759
Xiong, J.-W., Battaglino, R., Leahy, A., and Stuhlmann, H. (1998). Large-scale screening for developmental genes in ES cells and embryoid bodies using retroviral entrapment vectors.
Dev. Dyn. 212(2): 181-197. PMID: 9626494
Kuze, K., Graves, P., Leahy, A., Wilson, P., Stuhlmann, H., and You, G. (1999). Heterologous expression and functional characterization of a mouse renal organic anion transporter in mammalian cells. J. Biol. Chem. 274(3): 1519-1524. PMID: 9880528
Xiong, J.-W., Leahy, A., Lee, H.-H., and Stuhlmann, H. (1999). Vezf1: a Zn finger transcription factor restricted to endothelial cells and their precursors. Dev. Biol. 206(2): 123-
141. PMID: 9986727
Leahy, A., Xiong, J.-W., Kuhnert, F., and Stuhlmann, H. (1999). Use of developmental marker genes to define temporal and spatial patterns of differentiation during embryoid body formation.
J. Exp. Zool. 284(1): 67-81. PMID: 10368935
Xiong, J.-W., Leahy, A., and Stuhlmann, H. (1999). Promoter-trap insertion into a novel mammalian septin gene expressed during neuronal development. Mech. Dev. 86(1-2): 183-
191. PMID: 10446280
Gutstein, D.E., Morley, G.E., Tamaddon, H., Vaidya, D., Schneider, M.D., Chen, J., Chien, K.R., Stuhlmann, H., and Fishman, G.I. (2001). Genetic manipulation of connexin43 expression in the heart: establishing a role for gap junction remodeling in arrhythmogenesis and ventricular dysfunction. Circ. Res. 88(3): 333-339. PMID: 11179202
Gutstein, D.E., Morley, G.E., Vaidya, D., Liu, F., Chen, F.L., Stuhlmann, H., and Fishman, G.I. (2001). Heterogeneous expression of gap junction channels in the heart leads to conduction defects and ventricular dysfunction. Circulation 104(10): 1194-1199. PMID: 11535579
Eto, K., Murphy, R., Kerrigan, S.W., Bertoni, A., Stuhlmann, H., Nakano, T., Leavitt, A.D., and Shattil, S.J. (2002). Megakaryocytes derived from embryonic stem cells implicate CalDAG- GEFI in integrin signaling. Proc. Natl. Acad. Sci. USA 99(20): 12819-12824. PMID: 12239348
Macara, I.G., Baldarelli, R., Field, C.M., Glotzer, M., Hayashi, Y., Hsu, S.C., Kennedy, M.B., Kinoshita, M., Longtine, M., Low, C., Maltais, L.J., McKenzie, L., Mitchison, T.J., Nishikawa, T., Noda, M., Petty, E.M., Peifer, M., Pringle, J.R., Robinson, P.J, Roth, D., Russell, S.E., Stuhlmann, H., Tanaka, M., Tanaka, T., Trimble, W.S., Ware, J., Zeleznik-Le, N.J., Zieger, B. (2002). Mammalian septins nomenclature. Mol. Biol. Cell. 13(12): 4111-4113. PMID: 12475938
Hooper, J.D., Campagnolo, L., Goodarzi, G., Truong, T.N., Stuhlmann, H., and Quigley, J.P. (2003). Mouse matriptase-2: identification, characterization and comparative mRNA expression analysis with mouse hepsin in adult and embryonic tissues. Biochem. J. 373(3): 689-702. PMID: 12744720
Stuhlmann, H. (2003). “Gene trap vector screen for developmental genes in differentiating ES cells”. Methods Enzymol. 365: 386-406. PMID: 14696360
Fitch, M.J., Campagnolo, L., Kuhnert, F., and Stuhlmann, H. (2004). Egfl7, a novel epidermal growth factor-domain gene expressed in endothelial cells. Dev. Dyn. 230(2): 316-324. PMID: 15162510
Feral, C.C., Nishiya, N., Fenczik, C.A., Stuhlmann, H., Slepak, M., and Ginsberg, M.H. (2005). CD98hc (SLC3A2) mediates integrin signaling. Proc. Natl. Acad. Sci. USA 102(2): 355-360.
PMID: 15625115
Kuhnert, F., Campagnolo, L., Xiong, J.-W., Lemons, D., Fitch, M.J., Zou, Z., Kiosses, W.B., Gardner, H., and Stuhlmann, H. (2005). Dosage-dependent requirement for mouse Vezf1 in vascular system development. Dev. Biol. 283(1): 140-156. PMID: 15882861
Campagnolo, L., Leahy, A., Chitnis, S., Koschnik, S., Fitch, M.J., Fallon, J.T., Loskutoff, D., Taubman, M.B., and Stuhlmann, H. (2005). EGFL7 is a chemoattractant for endothelial cells and is up-regulated in angiogenesis and arterial injury. Am. J. Pathol. 167(1): 275-284. PMID: 15972971
Lewis, J.D., Destito, G., Zijlstra, A., Gonzalez, M.J., Quigley, J.P., Manchester, M., and Stuhlmann, H. (2006). Viral nanoparticles as tools for intravital vascular imaging. Nat. Med. 12(3): 354-360. PMID: 15972971
Zijlstra, A., Lewis, J.D., DeGryse, B., Stuhlmann, H., and Quigley, J.P. (2008). The inhibition of tumor cell intravasation and subsequent metastasis via regulation of in vivo tumor cell motility by the tetraspanin CD151. Cancer Cell 13: 221-234. PMID: 18328426
Campagnolo, L., Moscatelli, I., Pellegrini, M., Siracusa, G., and Stuhlmann, H. (2008). Expression of EGFL7 in primordial germ cells and in adult ovaries and testes. Gene Expr. Patterns 8: 389-396. PMID: 18556249
Gowher, H., Stuhlmann, H., and Felsenfeld, G. (2008). Vezf1 regulates genomic DNA methylation through its effect on expression of DNA methyltransferase Dnmt3b. Genes Dev. 22: 2075-2084. PMID: 18676812
Brunel, F.M., Lewis, J.D., Destito, G., Steinmetz, N.F., Manchester, M., Stuhlmann, H., and Dawson, P.E. (2010). Hydrazone ligation strategy to assemble multifunctional viral nanoparticles for cell imaging and tumor targeting. Nano Lett. 10:1093-1097. PMID: 20163184
Durrans, A. and Stuhlmann, H. (2010). A role for Egfl7 during endothelial organization in the embryoid body model system. J. Angiog. Res. 2(4):1-12. PMID: 20298530
Zou, Z., Ocaya, P.A., Sun, H., Kuhnert, F., and Stuhlmann, H. (2010). Targeted Vezf1-null mutation impairs vascular structure formation during embryonic stem cell differentiation. Ather. Thromb. Vasc. Biol. 30:1378-1388. PMID: 20431070
Leong, H.S., Steinmetz, N.F., Ablack, A., Destito, G., Zijlstra, A., Stuhlmann, H., Manchester, M., and Lewis, J.D. (2010). Intravital imaging of embryonic and tumor neovasculature using viral nanoparticles. Nature Prot. 5:1406-1417. PMID: 20671724
Nichol, D., Shawber, C.J.,Fitch, M.J., Bambino, K., Sharma, A., Kitajewski, J., Stuhlmann, H.
(2010)*. Impaired angiogenesis and altered Notch signaling in mice overexpressing Egfl7. Blood 116(26):6133-6143. PMID: 20947685
*Commentary: Davis, G. (2010). Vascular balancing act: EGFL7 and Notch. Blood 116 (26):5791-5793.
Salvi, S., Ferrazzani, S., Vecchione, L., Siracusa, G., Stuhlmann H., Campagnolo, L. (2011). P7. Role of EGF-like domain 7 (Egfl7) in placental development and implantation. Pregnancy Hypertens. 1(3-4):275-276. PMID: 26009097
Li, J. and Stuhlmann, H. (2012). In vitro imaging of angiogenesis using embryonic stem cell- derived endothelial cells. Stem Cells Dev. 21(2): 331-342. PMID: 21385073
Gerald, D., Adini, I., Shechter, S., Peruzzi, C., Varnau, J., Hopkins, B., Kazerounian, S., Kurschat, P., Blanchon, S., Khedkar, S., Bagchi, M., Sherris, D., Prendergast, G.C., Klagsbrunn, M., Stuhlmann, H., Rigby, A.C., Nagy, J.A., and Benjamin, L.E. (2013). RhoB controls coordination of adult angiogenesis and lymphangiogenesis following injury by regulating VEZF1-mediated transcription. Nat Commun. 4: 2824, pp. 1-15. PMID: 24280686
Bambino, K., Lacko, L.A., Hajjar, K.A., and Stuhlmann, H. (2014). Epidermal Growth Factor-like Domain 7 is a marker of the endothelial lineage and active angiogenesis. Genesis 52(7): 657- 670. PMID: 24740971
Lacko, L.A., Massimiani, M., Sones, J.L., Hurtado, R., Salvi, S., Ferrazzani, S., Davisson, R.L., Campagnolo, L., and Stuhlmann, H. (2014). Novel expression of EGFL7 in placental trophoblasts and endothelial cells and its implication in preeclampsia. Mech Dev. 133: 163-176. PMID: 24751645
Kao, D.I., Lacko, L.A., Ding, B.S., Huang, C., Phung, K., Gu, G., Rafii, S., Stuhlmann, H., and Chen, S. (2015). Endothelial cells control pancreatic cell fate at defined stages through EGFL7 signaling. Stem Cell Reports 4(2): 181-189. PMID: 24751645
Massimiani, M., Vecchione, L., Piccirilli, D., Spitalieri, P., Amati, F., Salvi, S., Ferrazzani, S., Stuhlmann, H., and Campagnolo, L. (2015). Epidermal growth factor-like domain 7 promotes migration and invasion of human trophoblast cells through activation of MAPK, PI3K and NOTCH signaling pathways. Mol Hum Reprod. 21(5): 435-451. PMID: 25667199
Campagnolo, L., Telesca, C., Massimiani, M., Stuhlmann, H., Angelico, M., Lenci, I., Manzia, T.M., Tariciotti, L., Lehmann, G., Baiocchi, L. (2015). Different expression of VEGF and EGFL7 in human hepatocellular carcinoma. Dig Liver Dis. 48(1):76-80. PMID: 26542361
Lacko, L.A., Hurtado, R., Hinds, S.G., Poulos, M.G., Butler, J.M., Stuhlmann, H. (2017). Altered feto-placental vascularization, fetal-placental malperfusion, and fetal growth restriction in mice with Egfl7 loss-of-function. Development 144(13):2469-2479. PMID: 28526753
Massimiani, M., Lacko L.A., Burke Swanson, C.S., Salvi, S., Argueta, L.B., Moresi, S., Ferrazzani, S., Gelber, S.E., Baergen, R.N., Toschi, N., Campagnolo, L., and Stuhlmann, H. (2019). Increased circulating levels of Epidermal Growth factor-like Domain 7 in women affected by preeclampsia. Transl. Res. 207: 19-29. [PMCID: PMC6486846]
Sharma, A., Lacko, L.A., Argueta, L., Glendinning, M. and Stuhlmann, H. (2019). miR-126 regulates glycogen trophoblast proliferation and DNA methylation in the murine placenta. Dev. Biol. 449(1):21-34. [PMCID: PMC6451886]
Tan, L., Lacko, L.A., Zhou, T., Tomoiaga, D., Hurtado, R., Zhang, T., Sevilla, A., Zhong, A., Mason, C.E., Noggle, S., Evans, T., Stuhlmann, H., Schwartz, R.E. and Chen, S. (2019). Pre- and peri-implantation Zika virus infection impairs fetal development by targeting trophectoderm cells. Nat. Commun. 10, Article number: 4155. [PMCID: PMC6744420 DOI: 10.1038/s41467- 019-12063-2].
Lustgarten Guahmich, N., Farber, G., Shafiei, S., McNally, D., Redmond, D., Kallinos, E., Stuhlmann, H., Dufort, D., James, D., Blobel, C.P. (2020). Endothelial Deletion of ADAM10, a Key Regulator of Notch Signaling, Causes Impaired Decidualization and Reduced Fertility in Female Mice. Angiogenesis May 8. doi: 10.1007/s10456-020-09723-z. PMID: 32385775.
Massimiani M, Tiralongo GM, Salvi S, Fruci S, Lacconi V, La Civita F, Mancini M, Stuhlmann H, Valensise H, Campagnolo L. (2021). Treatment of pregnancies complicated by intrauterine growth restriction with nitric oxide donors increases placental expression of Epidermal Growth Factor-Like Domain 7 and improves fetal growth: A pilot study. Transl. Res 228:28-41. PMID: 32784003 DOI: 10.1016/j.trsl.2020.08.002 .
Coelho-Santos V, Berthiaume AA, Ornelas S, Stuhlmann H, Shih AY. (2021). Imaging the construction of capillary networks in the neonatal mouse brain. Proc Natl Acad Sci U S A 118(26):e2100866118. PMCID: PMC8256089 DOI: 10.1073/pnas.2100866118 .
Massimiani M, Salvi S, Tiralongo GM, Moresi S, Stuhlmann H, Valensise H, Lanzone A, Campagnolo L. (2021). Circulating EGFL7 distinguishes between IUGR and PE: an observational case-control study. Sci Rep. 11(1):17919. PMCID: PMC8429426 DOI: 10.1038/s41598-021-97482-2 .
Argueta LB, Lacko LA, Bram Y, Tada T, Carrau L, Rendeiro AF, Zhang T, Uhl S, Lubor BC, Chandar V, Gil C, Zhang W, Dodson BJ, Bastiaans J, Prabhu M, Houghton S, Redmond D, Salvatore CM, Yang YJ, Elemento O, Baergen, RN, tenOever BR, Landau NR, Chen S, Schwartz RE, Stuhlmann H. (2022). Inflammatory responses in the placenta upon SARS-CoV-2 infection late in pregnancy. iScience 25 (5): 104223. [PMCID: PMC8996470 DOI: 10.1016/j.isci.2022.104223].
Chen RJ, Nabila A, Phalke S, Castro DF, Toth JG, Bergin P, Bastiaans J, Stuhlmann H, Pernis AB, Toth M. (2022). Serotonin-1A receptor, a psychiatric disease risk factor, influences offspring immunity via sex-dependent genetic nurture. iScience Nov 15; 25(12):105595. PMCID: PMC9706704 DOI: 10.1016/j.isci.2022.105595
Jin JC, Ananthanarayanan A, Brown JA, Rager SL, Bram Y, Sanidad KZ, Amir M, Baergen RN, Stuhlmann H, Schwartz RE, Perlman JM, Zeng MY. (2023). SARS CoV-2 detected in neonatal stool remote from maternal COVID-19 during pregnancy. Pediatr Res. Aug19;1-8. PMCID: PMC9388973 DOI: 10.1038/s41390-022-02266-7
Lacconi, V., Massimiani, M., Paglione, L., Antonaci, D., Meneghini, C., Klinger, F.G., Fazleabas, A., Stuhlmann, H., Rago, R., Ticconi, C., Campagnolo, L. (2023). Characterization of epidermal growth factor-like domain 7 (EGFL7) expression in normal endometrium and in the endometrium of women with poor reproductive outcomes. Hum Reprod. 38(7):13451358. doi: 10.1093/humrep/dead086
Chen, R.J., Nabila, A., Gal Toth, J., Stuhlmann, H., Toth, M. (2024). The chemokine XCL1 functions as a pregnancy hormone to program offspring innate anxiety. Brain Behav Immun. 118:178-189. https://doi.org/10.1016/j.bbi.2024.02.032
Salvi, S., Fruci, S., Lacconi, V., Totaro Aprile, F., Rullo, R., Stuhlmann, H., Lanzone, A., Campagnolo, L., Massimiani, M. (2024). Effect of Pravastatin on Placental Expression of Epidermal Growth Factor-like Domain 7 in Early-Onset Pre-Eclampsia: A New Potential Mechanism of Action. Biomedicines 12(8):1929. DOI: 10.3390/biomedicines12081929
Shahriar, S., Biswas, S., Zhao, K., Akcan, U., Tuohy, M.C., Glendinning, M.D., Kurt, A., Wayne, C.R., Prochilo, G., Price, M.Z., Stuhlmann, H., Brekken, R.A., Menon, V., Agalliu, D. (2024).
VEGF-A-mediated venous endothelial cell proliferation results in neoangiogenesis during neuroinflammation. Nat Neurosci. 27(10):1904-1917. DOI: 10.1038/s41593-024-01746-9
Reviews:
Nichol, D. and Stuhlmann, H. (2012). EGFL7: A unique angiogenic signaling factor in vascular development and disease. Review. Blood 119(6): 1345-1352. PMID: 22160377
Herbek, S.L., Smithgall, M.C., Murphy, E.A., Schwartz, R.E., Chen, S., Riley, L.E., Stuhlmann, H., Yang, Y.J., Goswami, R. (2022). Human Maternal-Fetal Interface Cellular Models to Assess Antiviral Drug Toxicity during Pregnancy. Review. Reprod Med. 3, 303–319.
DOI: 10.3390/reprodmed3040024
Book Chapters:
Jaenisch, R., Nobis, P., Jähner, D., and Stuhlmann, H. (1980). Molecular parameters and immunotherapy of leukemia in BALB/Mo mice. In: Viruses in Naturally Occurring Cancers. Cold Spring Harbor Conferences on Cell Proliferation, Vol. 7, Cold Spring Harbor Laboratory.
Kuhnert, F. and Stuhlmann, H. (2004). “Identifying early vascular genes through gene trapping in mouse ES cells”. Curr. Topics Dev. Biol. Vol. 62, chapter 9, pp. 261-281. PMID: 15625115
Kuhnert, F. and Stuhlmann, H. (2007). “Vezf1: a transcriptional regulator of the endothelium.” In:
Endothelial Biomedicine (ed: W.C. Aird), Cambridge University Press, New York; pp.855-860.
In Review (manuscripts submitted):
Bastiaans, J., Glendinning, M.D., de Marco Garcia, N., Stuhlmann, H. (2024). miR-126 modulates neural progenitor cell development. https://biorxiv.org/cgi/content/short/2024.12.27.630551v1
Rani, A., Arboleda, M., Stuhlmann, H. (2025). Aldehyde dehydrogenase protein: a placental glycogen trophoblast marker suitable to monitor placental pathologies in mouse models. https://www.biorxiv.org/cgi/content/short/2025.09.01.673566v1